Search results
Results From The WOW.Com Content Network
Beta blockers vary in their lipophilicity (fat solubility) and in turn in their ability to cross the blood–brain barrier and exert effects in the central nervous system. [76] Beta blockers with greater blood–brain barrier permeability can have both neuropsychiatric therapeutic benefits and side effects, as well as adverse cognitive effects ...
Atenolol is classified as a beta blocker with low lipophilicity and hence lower potential for crossing the blood–brain barrier and entering the brain. [44] This in turn may result in fewer effects in the central nervous system as well as a lower risk of neuropsychiatric side effects. [44] Only small amounts of atenolol are said to enter the ...
Metoprolol is classified as a moderately lipophilic beta blocker. [37] More lipophilic beta blockers tend to cross the blood–brain barrier more readily, with greater potential for effects in the central nervous system as well as associated neuropsychiatric side effects. [37] Metoprolol binds mainly to human serum albumin with an unbound ...
The β-blockers are an immensely important class of drugs due to their high prevalence of use. The discovery of β-blockers reaches back to more than 100 years ago, when early investigators came up with the idea that catecholamines were binding selectively to receptor-like structures and that this was the cause of their pharmacological actions. [3]
Bisoprolol, sold under the brand name Zebeta among others, is a beta blocker which is selective for the beta-1 receptor [7] and used for cardiovascular diseases, [7] including tachyarrhythmias, high blood pressure, angina, and heart failure.
Common side effects include dizziness, tiredness, joint pain, low blood pressure, nausea, and shortness of breath. [5] Severe side effects may include bronchospasm. [5] Safety during pregnancy or breastfeeding is unclear. [6] Use is not recommended in those with liver problems. [7] Carvedilol is a nonselective beta blocker and alpha-1 blocker. [5]
Levobunolol is a non-cardioselective beta blocker, that is, it blocks beta-1 receptors as well as beta-2 receptors. The latter type dominates in the ciliary body, where it controls aqueous humour production. Blocking this type of receptor reduces aqueous humour production, lowering intraocular pressure.
Mayo Clinic Health System is a system of community-based medical facilities. It is owned by Mayo Clinic and was founded in 1992. The organization focuses on providing medical care in rural communities in Minnesota , Iowa , and Wisconsin .